Cite
SA61CAN DNA METHYLATION PROFILING SHED LIGHT ON THE BIOLOGY OF CANNABIS ASSOCIATED PSYCHOSIS? PRELIMINARY DATA ON THE EWAS CANNABIS USE SIGNATURE IN THE EUGEI CASE-CONTROL STUDY.
MLA
Forti, Marta Di, et al. “Sa61can Dna Methylation Profiling Shed Light on the Biology of Cannabis Associated Psychosis? Preliminary Data on the Ewas Cannabis Use Signature in the Eugei Case-Control Study.” European Neuropsychopharmacology, vol. 29, Aug. 2019, p. S1221. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2018.08.283.
APA
Forti, M. D., Dempster, E., Quattrone, D., Hannon, E., Burrage, J., Mansell, G., Rutten, B., van Os, J., O’Donovan, M., Richards, A., Morgan, C., Murray, R., Wong, C. C. Y., & Mill, J. (2019). Sa61can Dna Methylation Profiling Shed Light on the Biology of Cannabis Associated Psychosis? Preliminary Data on the Ewas Cannabis Use Signature in the Eugei Case-Control Study. European Neuropsychopharmacology, 29, S1221. https://doi.org/10.1016/j.euroneuro.2018.08.283
Chicago
Forti, Marta Di, Emma Dempster, Diego Quattrone, Eilis Hannon, Joe Burrage, Georgina Mansell, Bart Rutten, et al. 2019. “Sa61can Dna Methylation Profiling Shed Light on the Biology of Cannabis Associated Psychosis? Preliminary Data on the Ewas Cannabis Use Signature in the Eugei Case-Control Study.” European Neuropsychopharmacology 29 (August): S1221. doi:10.1016/j.euroneuro.2018.08.283.